Monster Beverage (MNST) is expected to deliver another quarter of "strong" top-line growth, with UBS Securities forecasting Q3 organic sales to rise about 12%, roughly 34 basis points above Visible Alpha consensus.

The brokerage said in a Friday note that it estimates earnings of $0.48 per share, in line with Visible Alpha and about $0.02 above FactSet consensus. The firm added that it is above the Street on total revenue growth and gross margin, but below on operating margin.

UBS projects US sales growth of 9%, slightly above the 8% consensus, while international sales are expected to increase 17.6%, broadly in line with market estimates. The firm said growth remains "outsized" in Europe, supported by robust category momentum.

For the fourth quarter, UBS said quarter-to-date sales trends suggest growth in the low- to mid-teens range. It forecasts Q4 sales to increase 12%, about 323 basis points ahead of Visible Alpha's consensus of 8.8%.

The firm said Monster is likely to be one of the few consumer staples names this season to post strong organic growth and margin expansion despite headwinds from aluminum tariffs.

Monster Beverage is scheduled to report Q3 results on Thursday.

UBS maintained a neutral rating on the stock, with a $72 price target.